RodrÃguez-Lopez, A.; MejÃa-Abril, G.; Zubiaur, P.; Calleja, S.; Román, M.; Abad-Santos, F.; Ochoa, D.
Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals 2024, 17, 69.
https://doi.org/10.3390/ph17010069
AMA Style
RodrÃguez-Lopez A, MejÃa-Abril G, Zubiaur P, Calleja S, Román M, Abad-Santos F, Ochoa D.
Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals. 2024; 17(1):69.
https://doi.org/10.3390/ph17010069
Chicago/Turabian Style
RodrÃguez-Lopez, Andrea, Gina MejÃa-Abril, Pablo Zubiaur, SofÃa Calleja, Manuel Román, Francisco Abad-Santos, and Dolores Ochoa.
2024. "Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine" Pharmaceuticals 17, no. 1: 69.
https://doi.org/10.3390/ph17010069
APA Style
RodrÃguez-Lopez, A., MejÃa-Abril, G., Zubiaur, P., Calleja, S., Román, M., Abad-Santos, F., & Ochoa, D.
(2024). Use of Exposure Data to Establish Causality in Drug–Adverse Event Relationships: An Example with Desvenlafaxine. Pharmaceuticals, 17(1), 69.
https://doi.org/10.3390/ph17010069
